A phase I study of weekly topotecan (T) in combination with sorafenib (S) for treatment of relapsed or refractory small cell lung cancer (SCLC).

被引：0
|
作者：
Leach, J. W.
Swenson, K.
Anderson, E.
Menge, M. R.
Tsai, M. L.
机构：
[1] Pk Nicollet Inst, St Louis Pk, MN USA
[2] Frauenshuh Canc Ctr, Pk Nicollet Inst, St Louis Pk, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e18086
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18086
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A PHASE II STUDY OF WEEKLY GEMCITABINE-TOPOTECAN IN PRETREATED SMALL CELL LUNG CANCER (SCLC) PATIENTS (PTS)
    Domine, M.
    Gonzalez-Larriba, J. L.
    Lopez-Vilarino, J. A.
    Puente, J.
    Rubio, G.
    Alfonso, R.
    Martin-Valades, J. I.
    Rodriguez, L.
    Izarzugaza, Y.
    Lobo, F.
    ANNALS OF ONCOLOGY, 2010, 21 : 160 - 160
  • [22] A phase II trial of pazopanib in relapsed/refractory small cell lung cancer (SCLC).
    Gandhi, Leena
    Heist, Rebecca Suk
    Lucca, Joan Vern
    Temel, Jennifer S.
    Fidias, Panos
    Morse, Linda K.
    Johnson, Bruce E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] Phase II study of amrubicin and carboplatin in patients with the refractory or relapsed small cell lung cancer (SCLC).
    Hirose, T.
    Shirai, T.
    Kusumoto, S.
    Sugiyama, T.
    Yamaoka, T.
    Okuda, K.
    Ohmori, T.
    Ohnishi, T.
    Adachi, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] A phase II trial of combination chemotherapy with topotecan and amrubicin in small cell lung cancer (SCLC).
    Nogami, N.
    Kiura, K.
    Takigawa, N.
    Harita, S.
    Chikamori, K.
    Shibayama, T.
    Tabata, M.
    Hotta, K.
    Shinkai, T.
    Tanimoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Lurbinectedin (LUR) in combination with pembrolizumab (PBL) in relapsed small cell lung cancer (SCLC): The phase I/II LUPER study
    Blanco, A. Calles
    Mendivil, A. F. Navarro
    de Speville, B. Doger
    Colome, E. Alvarez
    Luken, M. J. De Miguel
    Alvarez, R. M.
    Garcia, V. Moreno
    Ramon, J.
    Valles, M. Arregui
    de la Fuente, E. Corral
    Alcala, D.
    Fernandez, M.
    Morato, J. Rodriguez
    Calvo, E.
    Sanchez, R. Palmero
    Jove, M.
    Felip, E.
    ANNALS OF ONCOLOGY, 2023, 34 : S1060 - S1061
  • [26] Weekly topotecan-gemcitabine for pretreated small cell lung cancer (SCLC) patients (pts): A phase II study.
    Domine, M.
    Gonzalez-Larriba, J. L.
    Lopez-Vilarino, J.
    Alfonso, R.
    Leon, A.
    Puente, J.
    Casado-Echarren, V.
    Rodriguez, L.
    Rubio, G.
    Lobo, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [27] Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer
    Naka, N
    Kawahara, M
    Okishio, K
    Hosoe, S
    Ogawara, M
    Atagi, S
    Takemoto, Y
    Ueno, K
    Kawaguchi, T
    Tsuchiyama, T
    Furuse, K
    LUNG CANCER, 2002, 37 (03) : 319 - 323
  • [28] Phase II Study of Weekly Amrubicin for Refractory or Relapsed Non-small Cell Lung Cancer
    Kitagawa, Chiyoe
    Iwasaku, Masahiro
    Kogure, Yoshihito
    Ando, Masahiko
    Yoshioka, Hiroshige
    Nishiyama, Akihiro
    Watanabe, Naoki
    Kunimasa, Kei
    Tsubouchi, Kazuya
    Oka, Saori
    Saka, Hideo
    IN VIVO, 2019, 33 (01): : 163 - 166
  • [29] A phase II study of second-line bendamustine in relapsed or refractory small cell lung cancer (SCLC)
    Lovly, Christine Marie
    Li, Chung-I
    Hutchison, Anne Smith
    Carbone, David Paul
    Johnson, David H.
    Keedy, Vicki Leigh
    Pao, William
    Sandler, Alan
    Horn, Leora
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [30] A phase II study of second-line bendamustine in relapsed or refractory small cell lung cancer (SCLC)
    Venepalli, N. K.
    Hutchison, A. S.
    Carbone, D. P.
    Johnson, D. H.
    Keedy, V. L.
    Pao, W.
    Sandler, A.
    Horn, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345